Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jul 12;7(7):CD015573.
doi: 10.1002/14651858.CD015573.

Treatment of uncomplicated hepatic cystic echinococcosis (hydatid disease)

Affiliations
Meta-Analysis

Treatment of uncomplicated hepatic cystic echinococcosis (hydatid disease)

Rebecca Kuehn et al. Cochrane Database Syst Rev. .

Abstract

Background: Cystic echinococcosis is a parasitic infection mainly impacting people living in low- and middle-income countries. Infection may lead to cyst development within organs, pain, non-specific symptoms or complications including abscesses and cyst rupture. Treatment can be difficult and varies by country. Treatments include oral medication, percutaneous techniques and surgery. One Cochrane review previously assessed the benefits and harms of percutaneous treatment compared with other treatments. However, evidence for oral medication, percutaneous techniques and surgery in specific cyst stages has not been systematically investigated and the optimal choice remains uncertain.

Objectives: To assess the benefits and harms of medication, percutaneous and surgical interventions for treating uncomplicated hepatic cystic echinococcosis.

Search methods: We searched CENTRAL, MEDLINE, two other databases and two trial registries to 4 May 2023. We searched the reference lists of included studies, and contacted experts and researchers in the field for relevant studies.

Selection criteria: We included randomized controlled trials (RCTs) in people with a diagnosis of uncomplicated hepatic cystic echinococcosis of World Health Organization (WHO) cyst stage CE1, CE2, CE3a or CE3b comparing either oral medication (albendazole) to albendazole plus percutaneous interventions, or to surgery plus albendazole. Studies comparing praziquantel plus albendazole to albendazole alone prior to or following an invasive intervention (surgery or percutaneous treatment) were eligible for inclusion.

Data collection and analysis: We used standard Cochrane methods. Our primary outcomes were symptom improvement, recurrence, inactive cyst at 12 months and all-cause mortality at 30 days. Our secondary outcomes were development of secondary echinococcosis, complications of treatment and duration of hospital stay. We used GRADE to assess the certainty of evidence.

Main results: We included three RCTs with 180 adults and children with hepatic cystic echinococcosis. Two studies enrolled people aged 5 to 72 years, and one study enrolled children aged 6 to 14 years. One study compared standard catheterization plus albendazole with puncture, aspiration, injection and re-aspiration (PAIR) plus albendazole, and two studies compared laparoscopic surgery plus albendazole with open surgery plus albendazole. The three RCTs were published between 2020 and 2022 and conducted in India, Pakistan and Turkey. There were no other comparisons. Standard catheterization plus albendazole versus PAIR plus albendazole The cyst stages were CE1 and CE3a. The evidence is very uncertain about the effect of standard catheterization plus albendazole compared with PAIR plus albendazole on cyst recurrence (risk ratio (RR) 3.67, 95% confidence interval (CI) 0.16 to 84.66; 1 study, 38 participants; very low-certainty evidence). The evidence is very uncertain about the effects of standard catheterization plus albendazole on 30-day all-cause mortality and development of secondary echinococcosis compared to open surgery plus albendazole. There were no cases of mortality at 30 days or secondary echinococcosis (1 study, 38 participants; very low-certainty evidence). Major complications were reported by cyst and not by participant. Standard catheterization plus albendazole may increase major cyst complications compared with PAIR plus albendazole, but the evidence is very uncertain (RR 10.74, 95% CI 1.39 to 82.67; 1 study, 53 cysts; very low-certainty evidence). Standard catheterization plus albendazole may make little to no difference on minor complications compared with PAIR plus albendazole, but the evidence is very uncertain (RR 1.03, 95% CI 0.60 to 1.77; 1 study, 38 participants; very low-certainty evidence). Standard catheterization plus albendazole may increase the median duration of hospital stay compared with PAIR plus albendazole, but the evidence is very uncertain (4 (range 1 to 52) days versus 1 (range 1 to 15) days; 1 study, 38 participants; very low-certainty evidence). Symptom improvement and inactive cysts at 12 months were not reported. Laparoscopic surgery plus albendazole versus open surgery plus albendazole The cyst stages were CE1, CE2, CE3a and CE3b. The evidence is very uncertain about the effect of laparoscopic surgery plus albendazole on cyst recurrence in participants with CE2 and CE3b cysts compared to open surgery plus albendazole (RR 3.00, 95% CI 0.13 to 71.56; 1 study, 82 participants; very low-certainty evidence). The second study involving 60 participants with CE1, CE2 or CE3a cysts reported no recurrence in either group. The evidence is very uncertain about the effect of laparoscopic surgery plus albendazole on 30-day all-cause mortality in participants with CE1, CE2, CE3a or CE3b cysts compared to open surgery plus albendazole. There was no mortality in either group (2 studies, 142 participants; very low-certainty evidence). The evidence is very uncertain about the effect of laparoscopic surgery plus albendazole on major complications in participants with CE1, CE2, CE3a or CE3b cysts compared to open surgery plus albendazole (RR 0.50, 95% CI 0.13 to 1.92; 2 studies, 142 participants; very low-certainty evidence). Laparoscopic surgery plus albendazole may lead to slightly fewer minor complications in participants with CE1, CE2, CE3a or CE3b cysts compared to open surgery plus albendazole (RR 0.13, 95% CI 0.02 to 0.98; 2 studies, 142 participants; low-certainty evidence). Laparoscopic surgery plus albendazole may reduce the duration of hospital stay compared with open surgery plus albendazole (mean difference (MD) -1.90 days, 95% CI -2.99 to -0.82; 2 studies, 142 participants; low-certainty evidence). Symptom improvement, inactive cyst at 12 months and development of secondary echinococcosis were not reported.

Authors' conclusions: Percutaneous and surgical interventions combined with albendazole can be used to treat uncomplicated hepatic cystic echinococcosis; however, there is a scarcity of randomised evidence directly comparing these interventions. There is very low-certainty evidence to indicate that standard catheterization plus albendazole may lead to fewer cases of recurrence, more major complications and similar complication rates compared to PAIR plus albendazole in adults and children with CE1 and CE3a cysts. There is very low-certainty evidence to indicate that laparoscopic surgery plus albendazole may result in fewer cases of recurrence or fewer major complications compared to open surgery plus albendazole in adults and children with CE1, CE2, CE3a and CE3b cysts. Laparoscopic surgery plus albendazole may lead to slightly fewer minor complications. Firm conclusions cannot be drawn due to the limited number of studies, small sample size and lack of events for some outcomes.

PubMed Disclaimer

Conflict of interest statement

RK: no relevant interests; works as a General Practitioner.

LU: no relevant interests; works as a health professional at the Ministry of Health, Río Negro Province, Argentina; affiliated to the World Association of Echinococcosis.

FT: no relevant interests; has published opinions in medical journals relevant to the interventions in the work; consultant on cystic echinococcosis.

Figures

1
1
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
1.1
1.1. Analysis
Comparison 1: Standard catheterization plus albendazole versus PAIR plus albendazole, Outcome 1: Recurrence
1.2
1.2. Analysis
Comparison 1: Standard catheterization plus albendazole versus PAIR plus albendazole, Outcome 2: Minor complications of treatment
2.1
2.1. Analysis
Comparison 2: Laparoscopic surgery plus albendazole versus open surgery plus albendazole, Outcome 1: Recurrence
2.2
2.2. Analysis
Comparison 2: Laparoscopic surgery plus albendazole versus open surgery plus albendazole, Outcome 2: Complications of treatment
2.3
2.3. Analysis
Comparison 2: Laparoscopic surgery plus albendazole versus open surgery plus albendazole, Outcome 3: Duration of hospital stay (days)

Similar articles

Cited by

References

References to studies included in this review

Ahmad 2020 {published data only}
    1. Ahmad U, Anwar A, Khan SA, Ain QU, Kamal M, Aman Z. Outcome of laparoscopic versus open surgery in patients with hydatid cyst of liver. Rawal Medical Journal 2020;45(4):806-9.
Akhan 2020 {published data only}
    1. Akhan O, Erdoğan E, Ciftci TT, Unal E, Karaağaoğlu E, Akinci D. Comparison of the long-term results of puncture, aspiration, injection and re-aspiration (PAIR) and catheterization techniques for the percutaneous treatment of CE1 and CE3a liver hydatid cysts: a prospective randomized trial. Cardiovascular and Interventional Radiology 2020;43(7):1034-40. [DOI: 10.1007/s00270-020-02477-7] - DOI - PubMed
Masood 2022 {published data only}
    1. Masood PF, Mufti GN, Wani SA, Sheikh K, Baba AA, Bhat NA, et al. Comparison of laparoscopic and open surgery in hepatic hydatid disease in children: feasibility, efficacy and safety. Journal of Minimal Access Surgery 2022;18(3):360-5. [DOI: 10.4103/jmas.JMAS_220_20] - DOI - PMC - PubMed

References to studies excluded from this review

Abbas 2006 {published data only}
    1. Abbas M, Nafeh AI, Youssef YF, Nasr MM, Radwan HS. Conservative versus radical surgery for treatment of uncomplicated hepatic hydatid cysts. Journal of the Egyptian Society of Parasitology 2006;36(2):559-76. - PubMed
Akhan 2002 {published data only}
    1. Akhan O, Abbasoglu O, Koroglu M, Ozmen MN, Sayek I, Akinci D. Percutaneous treatment versus surgery for liver hydatic cysts: preliminary results of a prospective randomized trial. Radiology 2002;225:397.
Akhan 2014 {published data only}
    1. Akhan O, Yildiz AE, Akinci D, Yildiz BD, Ciftci T. Is the adjuvant albendazole treatment really needed with PAIR in the management of liver hydatid cysts? A prospective, randomized trial with short-term follow-up results. Cardiovascular and Interventional Radiology 2014;37(6):1568-74. [DOI: 10.1007/s00270-014-0840-2] - DOI - PubMed
El Elshafey 2018 {published data only}
    1. El Elshafey H. Laparoscopic vs open approach in management of hepatic hydatid cystic disease. Journal of the American College of Surgeons 2018;227(4):e174. [DOI: 10.1016/j.jamcollsurg.2018.08.475] - DOI
Hamdy 2019 {published data only}
    1. Hamdy M, Fahmy K, Ahmed TY. Evaluation of laparoscopic versus open surgery in management of liver hydatid cyst: Ain Shams University experience. Tumori 2019;105(3):13.
Jabbari Nooghabi 2015 {published data only}
    1. Jabbari Nooghabi A, Mehrabi Bahar M, Asadi M, Jabbari Nooghabi M, Jangjoo A. Evaluation and comparison of the early outcomes of open and laparoscopic surgery of liver hydatid cyst. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2015;25(5):403-7. [DOI: 10.1097/SLE.0000000000000199] - DOI - PubMed
Khuroo 1993 {published data only}
    1. Khuroo MS, Dar MY, Yattoo GN, Zargar SA, Javaid G, Khan BA, et al. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993;104(5):1452-9. [DOI: 10.1016/0016-5085(93)90355-G] - DOI - PubMed
Khuroo 1997 {published data only}
    1. Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. New England Journal of Medicine 1997;337(13):881-7. [DOI: 10.1056/NEJM199709253371303] - DOI - PubMed
Minaev 2017 {published data only}
    1. Minaev SV, Gerasimenko IN, Kirgizov IV, Shamsiev AM, Bykov NI, Shamsiev JA, et al. Laparoscopic treatment in children with hydatid cyst of the liver. World Journal of Surgery 2017;41(12):3218-23. [DOI: 10.1007/s00268-017-4129-x] - DOI - PubMed
Shams‐Ul‐Bari 2011 {published data only}
    1. Shams-Ul-Bari, Arif SH, Malik AA, Khaja AR, Dass TA, Naikoo ZA. Role of albendazole in the management of hydatid cyst liver. Saudi Journal of Gastroenterology 2011;17(5):343-7. [DOI: 10.4103/1319-3767.84493] - DOI - PMC - PubMed
Shera 2017 {published data only}
    1. CTRI/2015/10/006231. Comparison of imaging guided injection treatment and surgery in hydatid cyst of liver [A comparison of imaging guided double percutaneous aspiration injection and surgery in treatment of cystic echinococcosis of liver]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2015/10/006231 (first received 1 December 2012).
    1. Shera TA, Choh NA, Gojwari TA, Shera FA, Shaheen FA, Wani GM, et al. A comparison of imaging guided double percutaneous aspiration injection and surgery in the treatment of cystic echinococcosis of liver. British Journal of Radiology 2017;90(1072):20160640. [DOI: 10.1259/bjr.20160640] - DOI - PMC - PubMed
Tuxun 2014 {published data only}
    1. Tuxun T, Aji T, Tai Q, Zhang J, Zhao J, Cao J, et al. Open versus laparoscopic treatment for cystic hydatid disease of liver: a 6-year single center experience. Journal of Gastrointestinal Surgery 2014;18(6):1155-60. [DOI: 10.1007/s11605-014-2494-4] - DOI - PubMed
Yüksel 2008 {published data only}
    1. Yüksel O, Akyürek N, Sahin T, Salman B, Azili C, Bostanci H. Efficacy of radical surgery in preventing early local recurrence and cavity-related complications in hydatic liver disease. Journal of Gastrointestinal Surgery 2008;12(3):483-9. [DOI: 10.1007/s11605-007-0301-1] - DOI - PubMed

References to studies awaiting assessment

CTRI/2013/07/003844 {published data only}
    1. CTRI/2013/07/003844. To see if there is any difference between a laparoscopic operation and a radiological procedure in the treatment of hydatid disease of liver [Laparoscopic intervention vs percutaneous techniques for hepatic hydatid disease]. ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=NjI2MA==&Enc=&us... (first received 26 July 2013). [CTRI NUMBER: CTRI/2013/07/003844]
Mijbas 2020 {published data only}
    1. Mijbas SA, Al-Hakkak SM, Alnajim AA, AL-Aquli HA. Laparoscopic or open treatment for liver hydatid cyst? A single-institution experience: a prospective randomized control trial. International Journal of Research in Pharmaceutical Sciences 2020;11(3):3088-95. [DOI: 10.26452/ijrps.v11i3.2417] - DOI
NCT01643018 {published data only}
    1. NCT01643018. Laparoscopic versus open surgery for the management of cystic echinococcosis of the liver. clinicaltrials.gov/study/NCT01643018 (first received 17 July 2012).

Additional references

Akhan 2017
    1. Akhan O, Salik AE, Ciftci T, Akinci D, Islim F, Akpinar B. Comparison of long-term results of percutaneous treatment techniques for hepatic cystic echinococcosis types 2 and 3b. American Journal of Roentgenology 2017;208(4):878-84. [DOI: 10.2214/AJR.16.16131] - DOI - PubMed
Balli 2019
    1. Balli O, Balli G, Cakir V, Gur S, Pekcevik R, Tavusbay C, et al. Percutaneous treatment of giant cystic echinococcosis in liver: catheterization technique in patients with CE1 and CE3a. Cardiovascular and Interventional Radiology 2019;42(8):1153-9. [DOI: 10.1007/s00270-019-02248-z] - DOI - PubMed
Balshem 2011
    1. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines – 3: rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [DOI: 10.1016/j.jclinepi.2010.07.015] - DOI - PubMed
Brehm 2000
    1. Brehm K, Koziol U. On the importance of targeting parasite stem cells in anti-echinococcosis drug development. Parasite (Paris, France) 2000;21:72. [DOI: 10.1051/parasite/2014070] - DOI - PMC - PubMed
Brehm 2014
    1. Brehm K, Koziol U. On the importance of targeting parasite stem cells in anti-echinococcosis drug development. Parasite (Paris, France) 2014;21:72. - PMC - PubMed
Brunetti 2010
    1. Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 2010;114(1):1-16. [DOI: 10.1016/j.actatropica.2009.11.001] - DOI - PubMed
Budke 2006
    1. Budke CM, Deplazes P, Torgerson PR. Global socioeconomic impact of cystic echinococcosis. Emerging Infectious Diseases 2006;12(2):296-303. [DOI: 10.3201/eid1202.050499] - DOI - PMC - PubMed
Bygott 2009
    1. Bygott JM, Chiodini PL. Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Tropica 2009;111(2):95-101. [DOI: 10.1016/j.actatropica.2009.04.006] - DOI - PubMed
Ceballos 2018
    1. Ceballos L, Krolewiecki A, Juárez M, Moreno L, Schaer F, Alvarez LI, et al. Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers. PLOS Neglected Tropical Diseases 2018;12(1):e0005945. [DOI: 10.1371/journal.pntd.0005945] - DOI - PMC - PubMed
Chebli 2017
    1. Chebli H, Laamrani El Idrissi A, Benazzouz M, Lmimouni BE, Nhammi H, Elabandouni M, et al. Human cystic echinococcosis in Morocco: ultrasound screening in the Mid Atlas through an Italian-Moroccan partnership. PLOS Neglected Tropical Diseases 2017;11(3):e0005384. [DOI: 10.1371/journal.pntd.0005384] - DOI - PMC - PubMed
Craig 2007
    1. Craig PS, Budke CM, Schantz PM, Li T, Qiu J, Yang Y, et al. Human echinococcosis: a neglected disease? Tropical Medicine and Health 2007;35(4):283-92. [DOI: 10.2149/tmh.35.283] - DOI
Deplazes 2017
    1. Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, et al. Global distribution of alveolar and cystic echinococcosis. Advances in Parasitology 2017;95:315-493. [DOI: 10.1016/bs.apar.2016.11.001] - DOI - PubMed
Franchi 1999
    1. Franchi C, Di Vico B, Teggi A. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clinical Infectious Diseases 1999;29:304-9. - PubMed
Gharbi 1981
    1. Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiology 1981;139(2):459-63. [DOI: 10.1148/radiology.139.2.7220891] - DOI - PubMed
Gollackner 2000
    1. Gollackner B, Langle F, Auer H, Maier A, Mittlbock M, Agstner I, et al. Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrence. World Journal of Surgery 2000;24:717-21. - PubMed
Higgins 2011
    1. Higgins JP, Altman DG, Sterne JA. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Higgins 2022
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Horton 2003
    1. Horton J. Albendazole for the treatment of echinococcosis. Fundamental & Clinical Pharmacology 2003;17(2):205-12. [DOI: 10.1046/j.1472-8206.2003.00171.x] - DOI - PubMed
Hosch 2008
    1. Hosch W, Junghanss T, Stojkovic M, Brunetti E, Heye T, Kauffmann GW, et al. Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents. NMR in Biomedicine 2008;21(7):734-54. [DOI: 10.1002/nbm.1252] - DOI - PubMed
Kapan 2006
    1. Kapan M, Kapan S, Goksoy E, Perek S, Kol E. Postoperative recurrence in hepatic hydatid disease. Journal of Gastrointestinal Surgery 2006;10:734-9. - PubMed
Kern 2017
    1. Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, et al. The echinococcoses: diagnosis, clinical management and burden of disease. Advances in Parasitology 2017;96:259-369. [DOI: 10.1016/bs.apar.2016.09.006] - DOI - PubMed
Larrieu 2004
    1. Larrieu E, Del Carpio M, Salvitti JC, Mercapide C, Sustersic J, Panomarenko H, et al. Ultrasonographic diagnosis and medical treatment of human cystic echinococcosis in asymptomatic school age carriers: 5 years of follow-up. Acta Tropica 2004;91(1):5-13. [DOI: 10.1016/j.actatropica.2004.02.006] - DOI - PubMed
Lefebvre 2023
    1. Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated October 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.
Lissandrin 2018
    1. Lissandrin R, Tamarozzi F, Mariconti M, Manciulli T, Brunetti E, Vola A. Watch and wait approach for inactive echinococcal cyst of the liver: an update. American Journal of Tropical Medicine and Hygiene 2018;99(2):375-9. [DOI: 10.4269/ajtmh.18-0164] - DOI - PMC - PubMed
McManus 2003
    1. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003;362(9392):1295-304. [DOI: 10.1016/S0140-6736(03)14573-4] - DOI - PubMed
Men 2006
    1. Men S, Yücesoy C, Edgüer TR, Hekimoğlu B. Percutaneous treatment of giant abdominal hydatid cysts: long-term results. Surgical Endoscopy 2006;20(10):1600-6. [DOI: 10.1007/s00464-005-0627-2] - DOI - PubMed
Menezes da Silva 2015
    1. Menezes da Silva A. Cystic echinococcosis in the liver: nomenclature and surgical procedures. Journal of Surgery and Surgical Research 2015;1(3):59-65. [DOI: 10.17352/2454-2968.000015] - DOI
Moroni 2016
    1. Moroni S, Moscatelli G, Bournissen FG, González N, Ballering G, Freilij H, et al. Abdominal cystic echinococcosis treated with albendazole. A pediatric cohort study. PLOS One 2016;11(9):e0160472. [DOI: 10.1371/journal.pone.0160472] - DOI - PMC - PubMed
Murad 2017
    1. Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. BMJ Evidence-Based Medicine 2017;22(3):85-7. [DOI: 10.1136/ebmed-2017-110668] - DOI - PMC - PubMed
Nasseri‐Moghaddam 2011
    1. Nasseri-Moghaddam S, Abrishami A, Taefi A, Malekzadeh R. Percutaneous needle aspiration, injection, and re-aspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No: CD003623. [DOI: 10.1002/14651858.CD003623.pub3] - DOI - PMC - PubMed
Piccoli 2014
    1. Piccoli L, Tamarozzi F, Cattaneo F, Mariconti M, Filice C, Bruno A, et al. Long-term sonographic and serological follow-up of inactive echinococcal cysts of the liver: hints for a "watch-and-wait" approach. PLOS Neglected Tropical Diseases 2014;8(8):e3057. [DOI: 10.1371/journal.pntd.0003057] - DOI - PMC - PubMed
Prousalidis 2008
    1. Prousalidis J, Kosmidis C, Anthimidis G, Fachantidis E, Harlaftis N, Aletras H. Forty-four years' experience (1963-2006) in the management of primarily infected hydatid cyst of the liver. HPB : the Official Journal of the International Hepato Pancreato Biliary Association 2008;10(1):18-24. - PMC - PubMed
RevMan 2024 [Computer program]
    1. Review Manager (RevMan). Version 7.7.1. The Cochrane Collaboration, 2024. Available at https://revman.cochrane.org.
Rinaldi 2014
    1. Rinaldi F, De Silvestri A, Tamarozzi F, Cattaneo F, Lissandrin R, Brunetti E. Medical treatment versus "Watch and Wait" in the clinical management of CE3b echinococcal cysts of the liver. BMC Infectious Diseases 2014;14:492. [DOI: 10.1186/1471-2334-14-492] - DOI - PMC - PubMed
Rogan 2006
    1. Rogan MT, Hai WY, Richardson R, Zeyhle E, Craig PS. Hydatid cysts: does every picture tell a story? Trends in Parasitology 2006;22(9):431-8. [DOI: 10.1016/j.pt.2006.07.003] - DOI - PubMed
Santivanez 2010
    1. Santivanez S, Garcia HH. Pulmonary cystic echinococcosis. Current Opinion in Pulmonary Medicine 2010;16(3):257-61. [DOI: 10.1097/MCP.0b013e3283386282] - DOI - PMC - PubMed
Schünemann 2022
    1. Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Siles‐Lucas 2017
    1. Siles-Lucas M, Casulli A, Conraths FJ, Müller N. Laboratory diagnosis of Echinococcus spp. in human patients and infected animals. Advances in Parasitology 2017;96:159-257. [DOI: 10.1016/bs.apar.2016.09.003] - DOI - PubMed
Solomon 2017
    1. Solomon N, Kachani M, Zeyhle E, Macpherson CN. The natural history of cystic echinococcosis in untreated and albendazole-treated patients. Acta Tropica 2017;171:52-7. [DOI: 10.1016/j.actatropica.2017.03.018] - DOI - PubMed
Stojkovic 2009
    1. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone R, et al. Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLOS Neglected Tropical Diseases 2009;3(9):e524. [DOI: 10.1371/journal.pntd.0000524] - DOI - PMC - PubMed
Stojkovic 2012
    1. Stojkovic M, Rosenberger K, Kauczor HU, Junghanss T, Hosch W. Diagnosing and staging of cystic echinococcosis: how do CT and MRI perform in comparison to ultrasound? PLOS Neglected Tropical Diseases 2012;6(10):e1880. [DOI: 10.1371/journal.pntd.0001880] - DOI - PMC - PubMed
Stojkovic 2016
    1. Stojkovic M, Rosenberger KD, Steudle F, Junghanss T. Watch and wait management of inactive cystic echinococcosis - does the path to inactivity matter - analysis of a prospective patient cohort. PLOS Neglected Tropical Diseases 2016;10(12):e0005243. [DOI: 10.1371/journal.pntd.0005243] - DOI - PMC - PubMed
Tamarozzi 2017
    1. Tamarozzi F, Hou A, Morales ML, Giordani MT, Vilca F, Mozo K, et al. Prevalence and risk factors for human cystic echinococcosis in the Cusco Region of the Peruvian Highlands diagnosed using focused abdominal ultrasound. American Journal of Tropical Medicine and Hygiene 2017;96(6):1472-7. - PMC - PubMed
Tamarozzi 2018
    1. Tamarozzi F, Akhan O, Cretu CM, Vutova K, Akinci D, Chipeva R, et al. Prevalence of abdominal cystic echinococcosis in rural Bulgaria, Romania, and Turkey: a cross-sectional, ultrasound-based, population study from the HERACLES project. Lancet Infectious Diseases 2018;18(7):769-78. [DOI: 10.1016/S1473-3099(18)30221-4] - DOI - PubMed
Tamarozzi 2020
    1. Tamarozzi F, Horton J, Muhtarov M, Ramharter M, Siles-Lucas M, Gruener B, et al. A case for adoption of continuous albendazole treatment regimen for human echinococcal infections. PLOS Neglected Tropical Diseases 2020;14(9):e0008566. [DOI: 10.1371/journal.pntd.0008566] - DOI - PMC - PubMed
Tamarozzi 2021
    1. Tamarozzi F, Silva R, Fittipaldo VA, Buonfrate D, Gottstein B, Siles-Lucas M. Serology for the diagnosis of human hepatic cystic echinococcosis and its relation with cyst staging: a systematic review of the literature with meta-analysis. PLOS Neglected Tropical Diseases 2021;15(4):e0009370. [DOI: 10.1371/journal.pntd.0009370] - DOI - PMC - PubMed
Vuitton 2020
    1. Vuitton DA, McManus DP, Rogan MT, Romig T, Gottstein B, Naidich A, et al. International consensus on terminology to be used in the field of echinococcoses. Parasite (Paris, France) 2020;27:41. [DOI: 10.1051/parasite/2020024] - DOI - PMC - PubMed
Wan 2022
    1. Wan L, Wang T, Cheng L, Yu Q. Laparoscopic treatment strategies for liver echinococcosis. Infectious Diseases and Therapy 2022;11(4):1415-26. [DOI: 10.1007/s40121-022-00664-2] - DOI - PMC - PubMed
Zhao 2021
    1. Zhao Y, Shen S, Jin X, Wang W, Li J, Chen W. Cell-free DNA as a diagnostic tool for human echinococcosis. Trends in Parasitology 2021;37(11):934-7. [DOI: 10.1016/j.pt.2021.07.006] - DOI - PubMed

References to other published versions of this review

CRD42023421407
    1. Kuehn R, Uchiumi LJ, Tamarozzi F. Treatment of cystic echinococcosis (hydatid disease): a systematic review. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=421407 (first received 25 April 2023). - PMC - PubMed

LinkOut - more resources